Filing Flows › Rockwell Medical (RMTI) › Q2 2026 › vs Q2 2025
Rockwell Medical (RMTI) Q2 2026 vs Q2 2025 (year over year)
Rockwell Medical's revenue rose $1.7M (+11%) from $16.1M in Q2 2025 to $17.8M in Q2 2026.
Rockwell Medical, Q2 2026: revenue $17.8M (+11% year over year), operating margin -6.0%, net loss $1.2M, operating cash flow $2.1M. The chart draws each line against Q2 2025, the increases inside each band.
Margins
| Q2 2026 | Q2 2025 | Change | |
|---|---|---|---|
| Free cash flow margin | 8.2% | 10.5% | -2.2 pts |
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $17.8M | $16.1M | $1.7M | +11% |
| Net loss | $1.2M | $1.5M | −$320K | -21% |
| Costs & expenses | $19.0M | $17.6M | $1.4M | +8% |
| Operating costs | $18.8M | $17.4M | $1.4M | +8% |
| Interest & other, net | $111K | $143K | −$32K | -22% |
| Cost of revenue | $14.5M | $13.6M | $969K | +7% |
| Sales & marketing | $577K | $572K | $5K | +0.9% |
| General & admin | $3.7M | $3.3M | $407K | +12% |
| Operating cash sources | $3.3M | $3.3M | −$84K | -3% |
| Depreciation & amortization | $492K | $563K | −$71K | -13% |
| Share-based compensation | $403K | $382K | $21K | +5% |
| Working capital & other | $2.4M | $2.4M | −$34K | -1% |
| Net loss absorbed | $1.2M | $1.5M | −$320K | -21% |
| Operating cash flow | $2.1M | $1.8M | $236K | +13% |
| Free cash flow (OCF − capex) | $1.5M | $1.7M | −$217K | -13% |
| Capital expenditures | $617K | $164K | $453K | +276% |
Questions
How much did Rockwell Medical's revenue grow year over year in Q2 2026?
Rockwell Medical's revenue rose $1.7M (+11%) from $16.1M in Q2 2025 to $17.8M in Q2 2026.